Badawia Bayoumy Ibrahim1, Mostafa Mohamed Salem2, Rasha Ahmed Khairy3, Reema Abdul Rahman Al Gunaid4. 1. Professor, Department of Pathology, Faculty of Medicine, Cairo University, Egypt. 2. Assistant Professor, Department of Pathology, Faculty of Medicine, Cairo University, Egypt. 3. Lecturer, Department of Pathology, Faculty of Medicine, Cairo University, Egypt. 4. PHD Student, Department of Pathology, Faculty of Medicine, Cairo University, Egypt.
Abstract
INTRODUCTION: In human cancers, podoplanin expression and its correlation with tumour invasive potential raise its possible role as a diagnostic and prognostic marker for cancer. AIM: To investigate the immunohistochemical expression of podoplanin in laryngeal Squamous Cell Carcinoma (SCC) and dysplasia. MATERIALS AND METHODS: This study included a total of 60 archived, formalin fixed, paraffin embedded tissue blocks of 40 cases of laryngeal SCC and 20 cases of dysplastic lesions. The samples were immunohistochemically analysed for podoplanin expression. RESULTS: Podoplanin expression was significantly higher in laryngeal SCC (90%) than laryngeal dysplastic lesions (55%) (p-value=0.002). The expression of podoplanin was significantly increased with the higher grades of dysplasia (p-value=0.016). A significant positive correlation was detected between podoplanin expression in laryngeal SCC and depth of tumour invasion (p-value=0.035), and stage (p-value=0.026). CONCLUSION: The high expression of podoplanin in laryngeal SCC and its significant correlation with poor prognostic parameters recommends podoplanin as a prognostic marker in laryngeal SCC. In addition, increased podoplanin expression with higher grades of dysplasia, supports its role in malignant transformation and allows us to recommend its evaluation in premalignant lesions.
INTRODUCTION: In humancancers, podoplanin expression and its correlation with tumour invasive potential raise its possible role as a diagnostic and prognostic marker for cancer. AIM: To investigate the immunohistochemical expression of podoplanin in laryngeal Squamous Cell Carcinoma (SCC) and dysplasia. MATERIALS AND METHODS: This study included a total of 60 archived, formalin fixed, paraffin embedded tissue blocks of 40 cases of laryngeal SCC and 20 cases of dysplastic lesions. The samples were immunohistochemically analysed for podoplanin expression. RESULTS:Podoplanin expression was significantly higher in laryngeal SCC (90%) than laryngeal dysplastic lesions (55%) (p-value=0.002). The expression of podoplanin was significantly increased with the higher grades of dysplasia (p-value=0.016). A significant positive correlation was detected between podoplanin expression in laryngeal SCC and depth of tumour invasion (p-value=0.035), and stage (p-value=0.026). CONCLUSION: The high expression of podoplanin in laryngeal SCC and its significant correlation with poor prognostic parameters recommends podoplanin as a prognostic marker in laryngeal SCC. In addition, increased podoplanin expression with higher grades of dysplasia, supports its role in malignant transformation and allows us to recommend its evaluation in premalignant lesions.
Authors: Annelienke M van Hulst; Wouter Kroon; Evi S van der Linden; Lily Nagtzaam; Sarah R Ottenhof; Inge Wegner; Amy C Gunning; Wilko Grolman; Weibel Braunius Journal: Head Neck Date: 2015-08-13 Impact factor: 3.147
Authors: Juan P Rodrigo; Dario García-Carracedo; María V González; Gonzalo Mancebo; Manuel F Fresno; Juana García-Pedrero Journal: Mol Cancer Date: 2010-03-02 Impact factor: 27.401
Authors: Matthias Kreppel; Anton Krakowezki; Barbara Kreppel; Uta Drebber; Inga Wedemeyer; Cornelia Mauch; Joachim E Zöller; Martin Scheer Journal: J Surg Oncol Date: 2012-08-06 Impact factor: 3.454
Authors: Philipp Wolber; David Schwarz; Maximilian Niemczyk; Uta Drebber; Jens Peter Klußmann; Moritz Meyer Journal: Eur Arch Otorhinolaryngol Date: 2020-01-18 Impact factor: 2.503